全文获取类型
收费全文 | 107813篇 |
免费 | 11270篇 |
国内免费 | 3186篇 |
专业分类
耳鼻咽喉 | 887篇 |
儿科学 | 1209篇 |
妇产科学 | 1041篇 |
基础医学 | 13158篇 |
口腔科学 | 3894篇 |
临床医学 | 11451篇 |
内科学 | 10280篇 |
皮肤病学 | 1402篇 |
神经病学 | 6844篇 |
特种医学 | 4504篇 |
外国民族医学 | 19篇 |
外科学 | 7568篇 |
综合类 | 16168篇 |
现状与发展 | 8篇 |
一般理论 | 3篇 |
预防医学 | 17444篇 |
眼科学 | 1382篇 |
药学 | 13875篇 |
122篇 | |
中国医学 | 5897篇 |
肿瘤学 | 5113篇 |
出版年
2024年 | 177篇 |
2023年 | 1916篇 |
2022年 | 2893篇 |
2021年 | 4948篇 |
2020年 | 5072篇 |
2019年 | 4410篇 |
2018年 | 3989篇 |
2017年 | 4290篇 |
2016年 | 4328篇 |
2015年 | 4279篇 |
2014年 | 7549篇 |
2013年 | 8123篇 |
2012年 | 7267篇 |
2011年 | 7655篇 |
2010年 | 5796篇 |
2009年 | 5410篇 |
2008年 | 5302篇 |
2007年 | 5259篇 |
2006年 | 4517篇 |
2005年 | 3925篇 |
2004年 | 3266篇 |
2003年 | 2975篇 |
2002年 | 2379篇 |
2001年 | 2179篇 |
2000年 | 1720篇 |
1999年 | 1423篇 |
1998年 | 1252篇 |
1997年 | 1117篇 |
1996年 | 977篇 |
1995年 | 1006篇 |
1994年 | 940篇 |
1993年 | 731篇 |
1992年 | 668篇 |
1991年 | 575篇 |
1990年 | 484篇 |
1989年 | 504篇 |
1988年 | 429篇 |
1987年 | 379篇 |
1986年 | 299篇 |
1985年 | 399篇 |
1984年 | 297篇 |
1983年 | 181篇 |
1982年 | 204篇 |
1981年 | 162篇 |
1980年 | 156篇 |
1979年 | 117篇 |
1978年 | 79篇 |
1977年 | 54篇 |
1976年 | 76篇 |
1974年 | 41篇 |
排序方式: 共有10000条查询结果,搜索用时 369 毫秒
21.
目的 克隆黄连(Coptis chinensis Franch.)中自然抗性相关巨噬细胞蛋白(Natural Resistance-Associated Macrophage Protein,NRAMP)的编码基因,并进行生物信息学分析。方法 从黄连基因组中比对NRAMP3基因,并根据比对的基因序列设计特异性引物,经PCR扩增得到的黄连NRAMP3编码序列,进行克隆、测序和生物信息学分析,并利用qPCR技术对黄连NRAMP3基因进行时空表达分析。结果 得到黄连NRAMP3基因cDNA序列,全长1617 bp,编码538个氨基酸,通过与GenBank上的其他蛋白序列比对,将其命名为CcNRAMP3;序列分析显示,黄连NRAMP3基因编码的氨基酸序列包含一个典型的NRAMP结构域(PF01566),有12个跨膜结构域,亚细胞定位于液泡膜上,具有疏水性强的特点。二级结构中肽链构象主要包括α-螺旋与无规则卷曲两部分;三级结构模型具有葡萄球菌锰转运突变体(MntH)的晶体结构。利用系统进化关系分析推测它可能具有转运重金属元素Cd功能。对黄连NRAMP3基因的组织表达分析表明,CcNRAMP3基因在黄连叶片中表达量最高。在遭受镉胁迫时,在须根中表达量先升高后降低,该基因很可能主要在根部对镉进行响应并发挥作用。结论 本研究首次通过克隆得到黄连NRAMP3基因,并运用生物信息学方法对其理化性质、结构特征等进行了分析预测,这些结果将为黄连NRAMP3基因的功能研究以及其对镉转运的调控机制提供理论依据和基因资源。 相似文献
22.
目的 本研究旨在探讨原发性高血压患者脉图参数与心血管危险分层的相关性,为原发性高血压患者心血管风险事件预警提供中医特色的依据。方法 采集435例原发性高血压患者的症状体征、脉象信息、生化指标等,分为低中危组、高危组、很高危组,采用单因素方差分析、秩和检验、有序logistic回归分析等方法,探讨原发性高血压患者脉图参数与心血管危险分层的相关性。结果 ①高血压低中危组→高危组→很高危组患者病程逐渐延长,两两组间比较有统计学差异;②高血压低中危组→高危组→很高危组患者的脉图参数H3/H1、H4/H1逐渐上升;高血压患者很高危组H5/H1、T1/T低于低中危组;③有序logistic回归分析结果显示,脉图参数T1、T4、T5、T为影响因素。结论 病程、血脂、肾功能是高血压患者心血管危险分层的影响因素之一。心血管危险分层等级的升高与脉图参数H3/H1、H4/H1、T5、T的升高及H5/H1、T4、T1的降低相关,说明脉图能一定程度上反映原发性高血压患者血管壁增厚、血管内壁受损、血管硬化及左心室收缩功能的减退程度。 相似文献
23.
《Saudi Pharmaceutical Journal》2022,30(11):1572-1588
Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of a metabolic syndrome caused by excessive accumulation of fat in the liver. Orthosiphon stamineus also known as Orthosiphon aristatus is a medicinal plant with possible potential beneficial effects on various metabolic disorders. This study aims to investigate the in vitro inhibitory effects of O. stamineus on hepatic fat accumulation and to further use the computational systems pharmacology approach to identify the pharmacokinetic properties of the bioactive compounds of O. stamineus and to predict their molecular mechanisms against NAFLD. Methods: The effects of an ethanolic extract of O. stamineus leaves on cytotoxicity, fat accumulation and antioxidant activity were assessed using HepG2 cells. The bioactive compounds of O. stamineus were identified using LC/MS and two bioinformatics databases, namely the Traditional Chinese Medicine Integrated Database (TCMID) and the Bioinformatics Analysis Tool for the Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). Pathway enrichment analysis was performed on the predicted targets of the bioactive compounds to provide a systematic overview of the molecular mechanism of action, while molecular docking was used to validate the predicted targets. Results: A total of 27 bioactive compounds corresponding to 50 potential NAFLD-related targets were identified. O. stamineus exerts its anti-NAFLD effects by modulating a variety of cellular processes, including oxidative stress, mitochondrial β-oxidation, inflammatory signalling pathways, insulin signalling, and fatty acid homeostasis pathways. O. stamineus is significantly targeting many oxidative stress regulators, including JNK, mammalian target of rapamycin (mTOR), NFKB1, PPAR, and AKT1. Molecular docking analysis confirmed the expected high affinity for the potential targets, while the in vitro assay indicates the ability of O. stamineus to inhibit hepatic fat accumulation. Conclusion: Using the computational systems pharmacology approach, the potentially beneficial effect of O. stamineus in NAFLD was indicated through the combination of multiple compounds, multiple targets, and multicellular components. 相似文献
24.
《Zeitschrift für medizinische Physik》2022,32(2):209-217
This work describes a measurement method for assessing dose-related image-quality of CT scans based on the difference detail curve (DDC) method, and showcases its use in a low contrast setting. The method is based on a phantom consisting of elliptical slices of different sizes into which contrast object modules can be inserted. These modules contain contrast objects based on (synthetic) resin mixtures with sucrose (native) or sodium iodine (contrast medium). Mixing ratios are provided to achieve a range of clinically relevant CT-numbers with these materials. The phantom is characterized in terms of contrast accuracy, energy dependency and long-term drift with satisfying results. Contrast accuracy and energy dependency are similar to that of water or soft tissue. Image quality of 655 scans of the phantom acquired at 30 different clinical institutions and with 16 different CT scanner models from 4 manufacturers was assessed by calculating a difference detail curve (DDC) from evaluation of up to 5 human observers using a custom-made software (RadiVates) described in this work. Based on these measurements, inter-observer variability was quantified using a bootstrap method and was shown to be a large contributor to the overall variability. This work demonstrates that assessment of CT image quality is feasible with the aforementioned phantom and DDC method. 相似文献
25.
26.
27.
Health systems around world are increasingly adopting cost-effectiveness (CE) analysis to inform decisions about access and reimbursement. We study how CE thresholds imposed by a health plan for granting reimbursement affect drug producers’ pricing incentives and patients’ access to new drugs. Analysing a sequential pricing game between an incumbent drug producer and a potential entrant with a new drug, we show that CE thresholds may have adverse effects for payers and patients. A stricter CE threshold may induce the incumbent to switch pricing strategy from entry accommodation to entry deterrence, limiting patients’ access to the new drug. Otherwise, irrespective of whether entry is deterred or accommodated, a stricter CE threshold is never pro-competitive and may in fact facilitate a collusive outcome with higher prices of both drugs. Compared to a laissez-faire policy, the use of CE thresholds when an incumbent monopolist is challenged by therapeutic substitutes can only increase the surplus of a health plan if it leads to entry deterrence. In this case the price reduction by the incumbent necessary to deter entry outweighs the health loss to patients who do not get access to the new drug. 相似文献
28.
《Journal of vascular and interventional radiology : JVIR》2022,33(6):631-638
PurposeTo test the following hypotheses: (a) balloon or stent assistance increases coil packing density (CPD) in the endovascular treatment of intracranial aneurysms, and (b) CPD correlates to ostium area (OA) and aneurysm volume (AV).Materials and MethodsThis retrospective study included 60 aneurysms (54 ruptured and 6 unruptured) treated with simple coiling (SC) (n = 18), balloon-assisted coiling (BAC) (n = 7), or stent-assisted coiling (SAC) (n = 35) at the authors’ institution between August 2017 and December 2019. AV and OA measurements were obtained from 3-dimensional digital subtraction angiography images using commercial software. Coil sizes were retrieved from patient files, and coil volume (CV) measurements were obtained from https://www.angiocalc.com/. Analysis of covariance, multivariate covariance analysis, and Pearson correlation analyses were performed.ResultsThe median value for AV, CV, CPD, and OA was 63.4 mm3 (range, 5.5–1,771.4 mm3), 23.13 mm3 (range, 2.03–296.95 mm3), 33.29% (range, 13.41%–81.02%), and 10.7 mm2 (range, 2.7–49.9 mm2), respectively. Multivariate analysis showed that the CPD values were not significantly different among the treatment groups, although OA significantly differed between the SC and SAC groups (P < .05). Pearson correlations showed that similar to AV, OA was negatively correlated with CPD (r = ?0.321, P < .05).ConclusionsThe CPD value in cerebral aneurysms treated with BAC or SAC did not differ from that in aneurysms treated with SC. 相似文献
29.
《Gait & posture》2022
BackgroundMarker-less systems based on digital video cameras and deep learning for gait analysis could have a deep impact in clinical routine. A recently developed system has shown promising results in terms of joint center position but has not been yet evaluated in terms of gait outcomes.Research questionHow does this novel marker-less system compare to a marker-based reference system in terms of clinically relevant gait parameters?MethodsThe deep learning method behind the developed marker-less system was trained on a dedicated dataset consisting of forty-one asymptomatic and pathological subjects each performing ten walking trials. The system could estimate the three-dimensional position of seventeen joint centers or keypoints (e.g., neck, shoulders, hip, knee, and ankles). We evaluated the marker-less system against a marker-based system in terms of differences in joint position (Euclidean distance), detection of gait events (e.g., heel strike and toe-off), spatiotemporal parameters (e.g., step length, time), kinematic parameters (e.g., hip and knee extension-flexion), and inter-trial reliability for kinematic parameters.ResultsThe marker-less system was able to estimate the three-dimensional position of joint centers with a mean difference of 13.1 mm (SD = 10.2 mm). 99% of the estimated gait events were estimated within 10 ms of the corresponding reference values. Estimated spatiotemporal parameters showed zero bias. The mean and standard deviation of the differences of the estimated kinematic parameters varied by parameter (for example, the mean and standard deviation for knee extension flexion angle were −3.0° and 2.7°). Inter-trial reliability of the measured parameters was similar to that of the marker-based references.SignificanceThe developed marker-less system can measure the spatiotemporal parameters within the range of the minimum detectable changes obtained using the marker-based reference system. Moreover, except for hip extension flexion, the system showed promising results in terms of several kinematic parameters. 相似文献
30.
《Journal of the American College of Radiology》2022,19(7):854-865
ObjectiveThe purpose of this study was to update trends, investigate sociodemographic disparities, and evaluate the impact on mortality of stroke neuroimaging across the United States from 2012 to 2019.MethodsRetrospective cohort study using CMS Medicare 5% Research Identifiable Files, representing consecutive ischemic stroke emergency department or hospitalized patients aged ≥65 years. A total of 85,547 stroke episodes with demographic and clinical information were analyzed using Cochran-Mantel-Haenszel tests and logistic regression. Outcome measures were neuroimaging (CT angiography [CTA], CT perfusion [CTP], MRI, MR angiography [MRA]) utilization, acute treatment (endovascular thrombectomy [EVT] and intravenous thrombolysis [IVT]), and mortality while in the hospital and at 30 days and 1 year post discharge.ResultsSignificantly increasing utilization trends for CTA (250%), CTP (428%) and MRI (18%), and a decreasing trend for MRA (?33%) were observed from 2012 to 2019 (P < .0001). Controlling for covariates in the logistic regression models, CTA and CTP were significantly associated with higher EVT and IVT utilization. Although CTA, MRI, and MRA were associated with lower mortality, CTP was associated with higher mortality post discharge. Less neuroimaging was performed in rural patients; older patients (≥80 years) had lower utilization of CTA, MRI, and MRA; female patients had lower rates of CTA; and Black patients had lower utilization of CTA and CTP.ConclusionsCTA and CTP utilization increased in the Medicare ischemic stroke population from 2012 to 2019 and both were associated with greater EVT and IVT use. However, disparities exist in neuroimaging utilization across all demographic groups, and further understanding of the root causes of these disparities will be crucial to achieving equity in stroke care. 相似文献